Could epigenome editing unlock more consistent cannabinoid yields?
Epigenome Editing for Cannabinoid Yield: Targets, Tools, and Priorities in Cannabis sativa.
AI Summary
Cannabis sativa cultivars can produce several-fold different amounts of cannabinoids even when they carry closely related, functional THCAS and CBDAS genes. Known genetic differences explain much of the broad distinction between drug-type and hemp chemotypes, but they do not fully account for these quantitative differences. The review highlights epigenetic regulation—changes in chromatin and DNA methylation that influence gene activity—as an additional factor affecting cannabinoid production.
Evidence points to tissue-specific chromatin switches in cannabinoid-producing glandular trichomes, while DNA methylation changes can accumulate during clonal propagation. Promoter-region methylation differences reached up to 22% by twenty subcultures, although their direct effects on cannabinoid yield remain unproven. UV treatment in Cannabis indica cell cultures was associated with an approximately 4-fold increase in CBDAS transcripts, but the study used a genome-wide methylation method and did not demonstrate a specific change at the CBDAS promoter. The proposed dCas9 epigenome-editing strategies could eventually help tune cannabinoid yields, but these approaches remain untested in Cannabis and require substantial mechanistic validation first.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Small lab study finds cannabis affected simulated driving and confidence
A lab method measures 17 cannabinoids across five hemp product types
A single-center study finds varied care and no recurrence in follow-up
Explore More Research
Stay informed about the latest cannabis science.